Raedler, L. A. (2016). Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus. Am Health Drug Benefits.
Παραπομπή Chicago StyleRaedler, Lisa A. "Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus." Am Health Drug Benefits 2016.
Παραπομπή MLARaedler, Lisa A. "Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus." Am Health Drug Benefits 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.